Shawn Tsuda1, Dmitry Oleynikov2, Jon Gould3, Dan Azagury4, Bryan Sandler5, Matthew Hutter6, Sharona Ross7, Eric Haas8, Fred Brody9, Richard Satava10. 1. Department of Surgery, University of Nevada School of Medicine, 1701 W. Charleston Blvd. Suite 400, Las Vegas, NV, 89102, USA. stsuda@medicine.nevada.edu. 2. Department of Surgery, University of Nebraska Medical Center, Omaha, NE, USA. 3. Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA. 4. Department of Surgery, Stanford School of Medicine, Stanford, CA, USA. 5. Department of Surgery, University of California San Diego School of Medicine, La Jolla, CA, USA. 6. Department of Surgery, Harvard Medical School, Boston, MA, USA. 7. Department of Surgery, Florida Hospital, Orlando, FL, USA. 8. Department of Surgery, University of Texas Medical School at Houston, Houston, TX, USA. 9. Department of Surgery, George Washington University, Washington, DC, USA. 10. Department of Surgery, University of Washington, Seattle, WA, USA.
Abstract
BACKGROUND: The da Vinci(®) Surgical System (Intuitive Surgical, Sunnyvale, CA, USA) is a computer-assisted (robotic) surgical system designed to enable and enhance minimally invasive surgery. The Food and Drug Administration (FDA) has cleared computer-assisted surgical systems for use by trained physicians in an operating room environment for laparoscopic surgical procedures in general, cardiac, colorectal, gynecologic, head and neck, thoracic and urologic surgical procedures. There are substantial numbers of peer-reviewed papers regarding the da Vinci(®) Surgical System, and a thoughtful assessment of evidence framed by clinical opinion is warranted. METHODS: The SAGES da Vinci(®) TAVAC sub-committee performed a literature review of the da Vinci(®) Surgical System regarding gastrointestinal surgery. Conclusions by the sub-committee were vetted by the SAGES TAVAC Committee and SAGES Executive Board. Following revisions, the document was evaluated by the TAVAC Committee and Executive Board again for final approval. RESULTS: Several conclusions were drawn based on expert opinion organized by safety, efficacy, and cost for robotic foregut, bariatric, hepatobiliary/pancreatic, colorectal surgery, and single-incision cholecystectomy. CONCLUSIONS: Gastrointestinal surgery with the da Vinci(®) Surgical System is safe and comparable, but not superior to standard laparoscopic approaches. Although clinically acceptable, its use may be costly for select gastrointestinal procedures. Current data are limited to the da Vinci(®) Surgical System; further analyses are needed.
BACKGROUND: The da Vinci(®) Surgical System (Intuitive Surgical, Sunnyvale, CA, USA) is a computer-assisted (robotic) surgical system designed to enable and enhance minimally invasive surgery. The Food and Drug Administration (FDA) has cleared computer-assisted surgical systems for use by trained physicians in an operating room environment for laparoscopic surgical procedures in general, cardiac, colorectal, gynecologic, head and neck, thoracic and urologic surgical procedures. There are substantial numbers of peer-reviewed papers regarding the da Vinci(®) Surgical System, and a thoughtful assessment of evidence framed by clinical opinion is warranted. METHODS: The SAGES da Vinci(®) TAVAC sub-committee performed a literature review of the da Vinci(®) Surgical System regarding gastrointestinal surgery. Conclusions by the sub-committee were vetted by the SAGES TAVAC Committee and SAGES Executive Board. Following revisions, the document was evaluated by the TAVAC Committee and Executive Board again for final approval. RESULTS: Several conclusions were drawn based on expert opinion organized by safety, efficacy, and cost for robotic foregut, bariatric, hepatobiliary/pancreatic, colorectal surgery, and single-incision cholecystectomy. CONCLUSIONS: Gastrointestinal surgery with the da Vinci(®) Surgical System is safe and comparable, but not superior to standard laparoscopic approaches. Although clinically acceptable, its use may be costly for select gastrointestinal procedures. Current data are limited to the da Vinci(®) Surgical System; further analyses are needed.
Authors: Kamran Ahmed; Mohammad Shamim Khan; Amit Vats; Kamal Nagpal; Oliver Priest; Vanash Patel; Joshua A Vecht; Hutan Ashrafian; Guang-Zhong Yang; Thanos Athanasiou; Ara Darzi Journal: Int J Surg Date: 2009-09-06 Impact factor: 6.071
Authors: Chan W Park; Edward C F Lam; Teresa M Walsh; Maxine Karimoto; Adrienne T Ma; Matthew Koo; Chet Hammill; Kenric Murayama; Cedric S F Lorenzo; Racquel Bueno Journal: Surg Endosc Date: 2011-05-26 Impact factor: 4.584
Authors: W A Draaisma; J P Ruurda; R C H Scheffer; R K J Simmermacher; H G Gooszen; H G Rijnhart-de Jong; E Buskens; I A M J Broeders Journal: Br J Surg Date: 2006-11 Impact factor: 6.939
Authors: Heidi Nelson; Daniel J Sargent; H Sam Wieand; James Fleshman; Mehran Anvari; Steven J Stryker; Robert W Beart; Michael Hellinger; Richard Flanagan; Walter Peters; David Ota Journal: N Engl J Med Date: 2004-05-13 Impact factor: 91.245
Authors: Cristiano G S Huscher; Andrea Mingoli; Giovanna Sgarzini; Gioia Brachini; Barbara Binda; Massimiliano Di Paola; Cecilia Ponzano Journal: Am J Surg Date: 2007-12 Impact factor: 2.565
Authors: Philippe Morel; Nicolas C Buchs; Pouya Iranmanesh; François Pugin; Leo Buehler; Dan E Azagury; Minoa Jung; Francesco Volonte; Monika E Hagen Journal: J Hepatobiliary Pancreat Sci Date: 2013-10-21 Impact factor: 7.027